RemSleep reports cytotoxicity test failures on DeltaWave cannula; new lab to retest

RemSleep Holdings Inc.

Two cytotoxicity tests on DeltaWave cannula MD, Angled Adaptor and Flexible Hose failed in early 2022.
Superior Toxicology & Wellness concluded original testing protocols were flawed and erroneous.
New third-party lab will conduct cytotoxicity tests with corrected procedures.
Initial tests by Product Safety Labs in New Jersey; both were failures.
CEO Tom Wood received letter from Dr. Joe Nieusma on March 25, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.